Feature Channels

Meeting News

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Keywords:

MS Drug Candidate Shows New Promise

Positive new data have been released on a drug candidate, RPC1063, for relapsing multiple sclerosis that was first discovered and synthesized at The Scripps Research Institute (TSRI).

View | Comment

Medicine

Channels:

Keywords:

New Targeted Radiosurgery Technology Provides Highly Accurate Treatment, Greater Patient Comfort

623327-image4.jpg

A new stereotactic radiosurgery system provides the same or a higher level of accuracy in targeting cancer tumors – but offers greater comfort to patients and the ability to treat multiple tumors at once – when compared to other radiation therapy stereotactic systems, according to researchers at Henry Ford Hospital in Detroit. Research results will be presented at ASTRO's 56th Annual Meeting.

View | Comment

Medicine

Channels:

Keywords:

Analysis Finds Select Group of Stage IV Lung Cancer Patient Population Achieves Long-Term Survival After Aggressive Treatments

A large, international analysis of patients with stage IV non-small cell lung cancer (NSCLC) indicates that a patient’s overall survival (OS) rate can be related to factors including the timing of when metastases develop and lymph node involvement, and that aggressive treatment for “low-risk” patients leads to a five-year OS rate of 47.8 percent, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.

View | Comment

Medicine

Channels:

Keywords:

Patients with Non-Small Cell Lung Cancer (NSCLC) Who Have Never Smoked or Who Have Quit Smoking Have Lower Risk of Developing Secondary Primary Lung Cancers Than Current Smokers

Non-small cell lung cancer (NSCLC) survivors who never smoked or who are former smokers at the time of diagnosis have a lower risk of developing secondary primary lung cancers (SPLC) compared to those who are current smokers, suggesting that increased tobacco exposure is associated with a higher risk of SPLC, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.

View | Comment

Medicine

Channels:

Keywords:

Long-Term Results of RTOG 0236 Confirm Good Primary Tumor Control and Positive Five-Year Survival Rates for Lung Cancer Patients Who Received Stereotactic Body Radiation Therapy

Patients with inoperable, early-stage lung cancer who receive stereotactic body radiation therapy (SBRT) have a five-year survival rate of 40 percent, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.

View | Comment

Medicine

Channels:

Keywords:

Patient Reported Data Indicates That Single Fraction Radiation Therapy Is as Effective as Multiple Fraction Radiation Therapy for Patients with Bone Metastases in a Broad Clinical Setting

A prospective study that compared patient-reported outcomes of a broad set of cancer patients with bone metastases demonstrates that single fraction radiation therapy (SFRT) is equally as effective as multiple fraction radiation therapy (MFRT) when pain, function and quality of life are considered, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.

View | Comment

Medicine

Channels:

Keywords:

Cancer Patients with Malignant Spinal Cord Compression Experienced Preserved Mobility When Administered One High-Dose of Radiation Therapy Compared to More Frequent Lower Doses of RT

Mobility is equally preserved in cancer patients suffering from malignant spinal cord compression (MSCC) who receive a single dose of 10 Gy of radiation therapy (RT), compared to patients who receive five daily doses of 4 Gy of RT each, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.

View | Comment

Medicine

Channels:

Keywords:

Chemotherapy and Stereotactic Ablative Radiation (SABR) Consecutively May Be Promising Treatment Option for Patients with Advanced Pancreatic Cancer

For patients with locally advanced pancreatic cancer, the combination of chemotherapy and stereotactic ablative radiation (SABR) may be a promising treatment option, ultimately allowing them to undergo surgery that may not otherwise be an option, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.

View | Comment

Medicine

Channels:

Keywords:

Long-Term Androgen Deprivation (LTAD) Therapy Combined with High-Dose Radiation Therapy (HDRT) for Prostate Cancer Improves Biochemical Control and Survival Rates

Prostate cancer patients who receive high-dose radiation therapy (HDRT) followed by a longer period of hormone suppression therapy, or androgen deprivation therapy (ADT), have higher five-year biochemical, disease-free survival (bDFS) and overall survival rates compared to patients who receive HDRT and a shorter duration of ADT, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.

View | Comment

Medicine

Channels:

Keywords:

Majority of Prostate Cancer Patients Surveyed Five Years After Treatment with Vessel-Sparing Radiation Therapy Report Preserved Sexual Function

A comparison of five-year sexual function outcomes, as reported by patients treated with external beam radiotherapy (EBRT) versus combination EBRT plus brachytherapy, indicates that the utilization of vessel-sparing radiation therapy makes cure possible without compromising long-term sexual function, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.

View | Comment